Induction of Microsomal NADPH-Cytochrome P-450 Reductase and Cytochrome P-450IVA1 (P-450laω) by Dehydroepiandrosterone in Rats: A Possible Peroxisomal Proliferator

Cancer Research

Volumn 49, Issue 9, 1989, Pages 2337-2343

  Wu, Hui Qiong ^a   Masset Brown, Judy ^a   Tweedie, Donald J ^a   Prough, Russell A ^a   Frenkel, Rene A ^b   Martin Wixtrom, Cheryl ^b   Estabrook, Ronald W ^b   Milewich, Leon ^c  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 REDUCTASE; PRASTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ENZYME INDUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; NONHUMAN; ORAL DRUG ADMINISTRATION; PEROXISOME PROLIFERATION; PRIORITY JOURNAL; RAT;

ANIMAL; BODY WEIGHT; CELL DIVISION; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; LIVER; MALE; MICROBODIES; NADPH-FERRIHEMOPROTEIN REDUCTASE; ORGAN WEIGHT; PRASTERONE; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024507717     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. VandeWiele, R. L., MacDonald, P. C., Gurpide, E., and Lieberman, S. Studies on the secretion and interconversion of androgens. Recent Prog. Horm. Res., 19:275–310, 1963.
2. Nyce, J. W., Magee, P. N., Hard, G. C., and Schwartz, A. G. Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in BALB/c mice with dehydroepiandrosterone. Carcinogenesis (Lond.), 5: 57–62, 1984.
3. Pashko, L. L., Rovito, R. J., Williams, J. R., Sobel, E. L., and Schwartz, A. G. Dehydroepiandrosterone (DHEA) and 3β-methyl-androst-5-cn-17-one: inhibitors of 7,12-dimethylbenz[a]anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin papilloma formation in mice. Carcinogenesis (Lond.), 5:463–466, 1984.
4. Schwartz, A. G., and Tannen, R. H. Inhibition of 7,12-dimethylbenz[a] anthracene- and urethane-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone. Carcinogenesis (Lond.), 5: 1335–1337, 1981.
5. Schwartz, B. Inhibition of spontaneous breast cancer formation in female C3H (Avy/e) mice by long-term treatment with dehydroepiandrosterone. Cancer Res., 39:1129–1132, 1979.
6. Yen, T. T., Allen, J. A., Pearson, D. V., Acton, J. M., and Greenberg, M. M. Prevention of obesity in Avy/e mice by dehydroepiandrosterone. Lipids, 72:409–413, 1977.
7. Coleman, D. L., Leiter, E. H., and Schwizer, R. W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes, 31: 830–833, 1982.
8. Lucas, J. A., Ahmed, S. A., Casey, M. L., and MacDonald, P. C. Prevention of autoantibody formation and prolonged survival in New Zealand black/ New Zealand white F1 mice fed dehydroisoandrosterone. J. Clin. Invest., 75: 2091–2093, 1985.
9. Tannen, R. H., and Schwartz, A. G. Reduced weight gain and delay of Coombs positive hemolytic anemia in NZB mice treated with dehydroepiandrosterone (DHEA). Fed. Proc., 41:463, 1982.
10. White, F. R. The relationship between underfeeding and tumor formation, transplantation, and growth in rats and mice. Cancer Res., 21: 281–290, 1961.
11. Hong, J.-Y., Pan, J., Dong, Z., Ning, S. M., and Yang, C. S. Regulation of N-nitrosodimethylamine demethylase in rat liver and kidney. Cancer Res., 47:5848–5953, 1987.
12. Remitier, H., Greim, H., Schenkman, J. B., and Estabrook, R. W. Methods for the elevation of hepatic microsomal mixed function oxidase levels and cytochrome P-450. Methods Enzymol., 10:703–708, 1967.
13. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265–275, 1951.
14. Masters, B. S. S., Williams, C. H., Jr., and Kamin, H. The preparation and properties of microsomal TPNH-cytochrome c reductase from hog liver. Methods Enzymol., 10:565–573, 1967.
15. Lind, G., and Ernster, L. A possible relationship between DT diaphorase and the aryl hydrocarbon hydroxylase system. Biochem. Biophys. Res. Commun., 56:392–400, 1974.
16. Omura, T., and Sato, R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239: 2370–2378, 1964.
17. Warholm, M., Guthenberg, C., von Bahr, G., and Mannervik, B. Glutathione transferases from human liver. Methods Enzymol., 113:499–501, 1985.
18. LaDu, B. N., Mandel, H. G., and Way, E. L. (eds.). Fundamentals of Drug Metabolism and Drug Disposition, pp. 569–572. Baltimore: Williams & Wilkins, 1971.
19. Nash, T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. J. Biol. Chem., 55:416–421, 1953.
20. Prough, R. A., Burke, M. D., and Mayer, R. T. Direct fluorometric methods for measuring mixed-function oxidase activity. Methods Enzymol., 52:372–377, 1978.
21. Okita, R. T., and Chance, G. Induction of laurate ω-hydroxylase by di(2-ethylbexyl)phthalate in rat liver microsomes. Biochem. Biophys. Res. Commun., 121:304–309, 1984.
22. Wood, A. W., Ryan, D. E., Thomas, P. E., and Levin, W. Regio- and stereoselective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P-450 isozymes. J. Biol. Chem., 258: 8839–8847, 1983.
23. Lazarow, P. B. Assay of peroxisomal β-oxidation of fatty acids. Methods Enzymol., 72:315–319, 1981.
24. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Nad. Acad. Sci. USA, 76:4350–4353, 1979.
25. Yasokochi, Y., and Masters, B. S. S. Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J. Biol. Chem., 251:5337–5344, 1976.
26. Prough, R. A., and Burke, M. D. The role of NADPH-cytochrome c reductase in microsomal hydroxylation reactions. Arch. Biochem. Biophys., 170:160–168, 1975.
27. Tamburini, P. P., Masson, H. A., Bains, S. K., Makowski, R. J., Morris, B., and Gibson, G. G. Multiple forms of hepatic cytochrome P-450. Purification, characterization and comparison of a novel clofibrate-induced isozyme with other major forms of cytochrome P-450. Eur. J. Biochem., 139: 235–246, 1984.
28. Schwartz, A., Hard, G., Pashko, L., Abou-Gharbia, M., and Swern, D. Dehydroepiandrosterone: an anti-obesity and anti-carcinogenic agent. Nutr. Cancer, 3:46–53, 1981.
29. Geary, M. P., Shepherd, A., Ziske, J., and Schwartz, A. Effect of dehydroepiandrosterone on body weight and food intake in rats. Nutr. Behav., 1: 127–136, 1983.
30. Nebert, D. W., Adesnik, M., Coon, M. J., Estabrook, R. W., Gonzalez, F. J., Guengerich, F. P., Gunsalus, I. G., Johnson, E. F., Kemper, B., Levin, W., Phillips, I. R., Sato, R., and Waterman, M. R. The P450 gene superfamily: recommended nomenclature. DNA, 6:1–11, 1987.
31. Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V., and Kaminsky, L. S. Purification and characterization of liver microsomal cytochromes P450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry, 21:6019–6030, 1982.
32. Waxman, D. J. Rat hepatic cytochrome P-450. Comparative study of multiple isozymic forms. In: P. R. Ortiz dcMontellano (ed.), Cytochrome P-450. Structure, Mechanism, and Biochemistry, pp. 525–539. New York: Plenum Publishing Corp., 1987.
33. Hawkins, J. M., Jones, W. E., Bonner, F. W., and Gibson, G. G. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in liver and kidney. Drug Metab. Rev., 18:441–515, 1987.
34. Rao, M. D., and Reddy, J. K. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis (Lond.), 8:631–636, 1987.
35. Prasanna, H. R., Schwartz, A., Hacobian, N., and Magee, P. N. Effects of feeding dehydroepiandrosterone (DHEA) on the hepatic metabolism of 7,12-dimethylbenzanthracene (DMBA) in rats. Fed. Proc., 46:2029, 1987.
36. Masters, B. S. S., and Okita, R. T. The history, properties, and function of NADPH-cytochrome P450 reductase. Pharmacol. Thcr., 9:227–244, 1980.
37. Ishii, H., Fukumori, N., Horie, S., and Suga, T. Effects of fat content in the diet on hepatic peroxisomes of the rat. Biochim. Biophys. Acta, 617:1–11, 1980.
38. Reddy, J. K., Lalwani, N. D., Dabholkar, A. S., Reddy, M. K., and Qureshi, S. A. Increased peroxisomal activity in the liver of vitamin E deficient rats. Biochem. Int., 3:41–49, 1981.
39. Reddy, J. K., Krishnakantha, T. P., Azarnoff, D. L., and Moody, D. E. 1-Methyl-4-piperidyl-bis-(p-chlorophenoxy)acetate. A new hypolipidemic peroxisome proliferator. Res. Commun. Chem. Pathol. Pharmacol., 10: 589–592, 1975.
40. Vainio, H., Linnainmaa, K., Kahonen, M., Nickels, J., Hietanen, E., Marniemi, J., and Pelkonen, P. Hypolipidemia and peroxisome proliferation induced by phenoxyacetic acid herbicides in rats. Biochem. Pharmacol., 32: 2775–2779, 1983.
41. Leighton, B., Tagliaferro, A. R., and Newsholme, E. A. The effect of dehydroepiandrosterone acetate on liver peroxisomal enzyme activities of male and female rats. J. Nutr., 117:1287–1290, 1987.